Supplementary Table S3 from Phase I...

Supplementary Table S3 from Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of AGS15E Monotherapy in Patients with Metastatic Urothelial Carcinoma

Abstract

<p>Supplementary Table S3. SLITRK6 Expression Levels, H-Score: Parts A, B, and C, Expansion Phase (FAS)</p>

Petrylak DP; Eigl BJ; George S; Heath EI; Hotte SJ; Chism DD; Nabell LM; Picus J; Cheng SY; Appleman LJ

January 5, 2024

10.1158/1078-0432.24947817.v1

Sebastien Hotte